Attention to improving clinical work and scientific research of peritoneal dialysis in China

Abstract

Peritoneal dialysis (PD) can be a simple and convenient, safe and effective home treatment, and has become an alternative treatment for end-stage renal disease. China is the most populous country, and the number of PD patients continued to rise in recent years with both the popularity of urban and rural basic medical insurance system and the national health policy control. PD in China is facing new opportunities and challenges, and it is imperative to pay attention to clinical technological improvements and scientific research and exploration of PD in China. The present editorial aimed to introduce the situation and challenge of PD in China, optimize the individualized PD treatment regimen for Chinese patients in order to improve the quality of treatment by evidence-based medicine, strengthen the management of quality control, strive to build PD treatment homogeneity, consolidate PD research foundation, and expand the product area of PD-related independent intellectual property, so as to provide new thoughts for clinical and basic research on PD to get greater social and economic benefits. Key words: Peritoneal dialysis; End-stage renal disease; Continuous ambulatory peritoneal dialysis

Ähnliche Arbeiten